FDA and CMS: A Path for Parallel Approvals for Innovative Technologies

01 April 2012 Medical Design Publication
Authors: Judith A. Waltz

Medical Design

Partner Judith Waltz authored an article that appeared in Medical Design on April 1, 2012 titled "FDA and CMS: A path for parallel approvals for innovative technologies." 

Click here to read the complete article.

Related Services

Insights

A Review of Recent Whistleblower Developments
19 July 2019
Legal News: Whistleblower Developments
Cloud security inadequate for Cyber threats, are you surprised?
19 July 2019
Internet, IT & e-Discovery Blog
Blockchain: A Tool With a Future in Healthcare
18 July 2019
Health Care Law Today
Do You Know What IMMEX Stands For?
16 July 2019
Dashboard Insights
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
2019 NDI Executive Exchange
14-15 November 2019
Chicago, IL
MAGI’s Clinical Research Conference
29 October 2019
Las Vegas, NV
Association for Corporate Counsel Annual Meeting 2019
27-30 October 2019
Phoenix, AZ